Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 67-72 , 25 January 2010

BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide

  • Yukie Matsumoto

      Affiliations

    • Department of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine, Tochigi, Japan
  • ,
  • Tetsuji Kobata

      Affiliations

    • Department of Immunology, Dokkyo Medical University School of Medicine, Tochigi, Japan
  • ,
  • Masaaki Odaka

      Affiliations

    • Department of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine, Tochigi, Japan
  • ,
  • Koichi Furukawa

      Affiliations

    • Department of Biochemistry II, Nagoya University School of Medicine, Nagoya, Japan
  • ,
  • Koichi Hirata

      Affiliations

    • Department of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine, Tochigi, Japan
  • ,
  • Nobuhiro Yuki

      Affiliations

    • Department of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine, Tochigi, Japan
    • Departments of Neurology and Clinical Research, Niigata National Hospital, Niigata, Japan
    • Corresponding Author InformationCorresponding author. Departments of Neurology and Clinical Research, Niigata National Hospital, 3-52 Akasaka, Kashiwazaki, Niigata 945-8585, Japan.

Received 15 July 2009 ,Revised 15 September 2009 ,Accepted 14 October 2009.

References 

  1. Balázs M, Martin F, Zhou T, Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity. 2002;17:341–352
  2. Barral P, Eckl-Dorna J, Harwood NE, de Santo C, Salio M, Illarionov P, et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008;105:8345–8350
  3. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood. 2003;102:956–963
  4. Brodeur SR, Angelini F, Bacharier LB, Blom AM, Mizoguchi E, Fujiwara H, et al. C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity. 2003;18:837–848
  5. Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, et al. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2004;101:3903–3908
  6. Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 2000;192:953–964
  7. Dye JR, Palvanov A, Guo B, Rothstein TL. B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-κB activation. J. Immunol. 2007;179:229–235
  8. Gerondakis S, Grumont RJ, Banerjee A. Regulating B-cell activation and survival in response to TLR signals. Immunol. Cell Biol. 2007;85:471–475
  9. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000;404:995–999
  10. Hafer-Macko C, Hsieh S-T, Li CY, Ho TW, Sheikh K, Cornblath DR, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 1996;40:635–644
  11. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré syndrome. Ann. Neurol. 1999;45:168–173
  12. Kawai T, Akira S. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 2007;13:460–469
  13. Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, et al. Comprehensive analysis of bacterial risk factors for the development of Guillain–Barré syndrome after Campylobacter jejuni enteritis. J. Infect. Dis. 2006;193:547–555
  14. Leadbetter EA, Brigl M, Illarionov P, Cohen N, Luteran MC, Pillai S, et al. NK T cells provide lipid antigen-specific cognate help for B cells. Proc. Natl. Acad. Sci. U. S. A. 2008;105:8339–8344
  15. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002;3:822–829
  16. Lunn MP, Johnson LA, Fromholt SE, Itonori S, Huang J, Vyas AA, et al. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J. Neurochem. 2000;75:404–412
  17. Matsumoto Y, Yuki N, Van Kaer L, Furukawa K, Hirata K, Sugita M. Guillain–Barré syndrome-associated IgG responses to gangliosides are generated independently of CD1 function in mice. J. Immunol. 2008;180:39–43
  18. Otipoby KL, Sasaki Y, Schmidt-Supprian M, Patke A, Gareus R, Pasparakis M, et al. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc. Natl. Acad. Sci. U. S. A. 2008;105:12435–12438
  19. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain–Barré syndrome. N. Engl. J. Med. 1995;333:1374–1379
  20. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293:2111–2114
  21. Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, Rao SP, et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 2004;173:2331–2341
  22. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 2007;27:3956–3967
  23. Takamiya K, Yamamoto A, Furukawa K, Yamashiro S, Shin M, Okada M, et al. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. U. S. A. 1996;93:10662–10667
  24. Takeda K, Akira S. Toll receptors and pathogen resistance. Cell. Microbiol. 2003;5:143–153
  25. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001;293:2108–2111
  26. von Bülow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity. 2001;14:573–582
  27. Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 2000;275:35478–35485
  28. Yuki N, Ichihashi Y, Taki T. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain–Barré syndrome. J. Neuroimmunol. 1995;60:161–164
  29. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl. Acad. Sci. U. S. A. 2004;101:11404–11409
  30. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S. Close association of Guillain–Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J. Neuroimmunol. 1997;74:30–34
  31. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, et al. A bacterium lipopolysaccharide that elicits Guillain–Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 1993;178:1771–1775
  32. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, et al. Animal model of axonal Guillain–Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 2001;49:712–720
  33. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 1990;40:1900–1902

PII: S0165-5728(09)00402-0

doi: 10.1016/j.jneuroim.2009.10.010

Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 67-72 , 25 January 2010